Inhibition of Decay-Accelerating Factor (CD55) Attenuates Prostate Cancer Growth and Survival In Vivo
Decay-accelerating factor (CD55) is a member of membrane-bound complement-regulatory proteins. CD55 expression correlates with poor survival in patients with colorectal cancer and has been implicated in the survival and tumorigenesis of blood-borne malignancies. Histologic analysis of clinical spec...
Main Authors: | Robert D. Loberg, LaShon L. Day, Rodney Dunn, Linda M. Kalikin, Kenneth J. Pienta |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2006-01-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558606800436 |
Similar Items
-
Lack of Association of CD55 Receptor Genetic Variants and Severe Malaria in Ghanaian Children
by: Kathrin Schuldt, et al.
Published: (2017-03-01) -
Equilibrium and Kinetics of Sin Nombre Hantavirus Binding at DAF/CD55 Functionalized Bead Surfaces
by: Tione Buranda, et al.
Published: (2014-03-01) -
Flow cytometric analysis of CD55 and CD59 expression on blood cells in paroxysmal nocturnal haemoglobinuria
by: Anna Czyz, et al.
Published: (2011-08-01) -
Incorporation of CD55 into the Zika Viral Envelope Contributes to Its Stability against Human Complement
by: Zahra Malekshahi, et al.
Published: (2021-03-01) -
Production of ULBP1-KO pigs with human CD55 expression using CRISPR technology
by: Agnieszka Nowak-Terpiłowska, et al.
Published: (2020-01-01)